CLINICAL_TRIALS
trial_result
· 2022-05-16
Clinical Trial Update: The Effect of Intranasal Oxytocin on Pain Sensitivity and Threshold [Phase 4]
Summary
Phase 4 clinical trial evaluating intranasal oxytocin on pain sensitivity and threshold in healthy individuals has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Northwestern University | Conditions: Healthy | Phase 4 | Status: COMPLETED | Results posted: 2022-05-16